首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.
【2h】

Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.

机译:吲哚类杆菌和脑膜炎杆菌对头孢吡肟和头孢吡肟的敏感性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In vitro activities of cefepime and cefpirome against 96 isolates of Chryseobacterium indologenes and 21 of C. meningosepticum were determined by the agar dilution method. Overall, cefepime was more active than cefpirome against C. indologenes (MIC at which 50% of the isolates were inhibited [MIC50] and MIC90, 4 and 16 microg/ml, respectively, for cefepime and 8 and 128 microg/ml, respectively, for cefpirome). Both agents had poor potency against C. meningosepticum (MIC50 and MIC90, 64 and >256 microg/ml, respectively, for cefepime and 128 and >256 microg/ml, respectively, for cefpirome).
机译:用琼脂稀释法测定了头孢吡肟和头孢吡肟对96株吲哚氏产链霉菌和21株脑膜炎梭菌的体外活性。总体而言,头孢吡肟对头孢梭菌的活性要比头孢吡肟高(MIC抑制了50%的分离物[MIC50]和MIC90,头孢吡肟和MIC90分别被抑制为4和16 microg / ml,对于头孢哌啶)。两种药物对脑膜炎梭菌的效价均较差(头孢吡肟的MIC50和MIC90分别为64和> 256 microg / ml,头孢哌酮的分别为128和> 256 microg / ml)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号